Alvacan is a product line of therapeutic cancer vaccines that combines the best of classical and oncolytic immunotherapy with recombinant DNA / RNA technology.
The flagship Alvacan 4000 combines the best of classic cancer vaccines with recombinant RNA / DNA technology
Alvacan 4000 is a patient-friendly vaccine that is well-suited for a wide range of cancer diagnoses. The patient's own Antigen Presenting Cells (APC) are boosted by recombinant DNA / RNA. The product is expected to be very effective, and with few side effects.
Alvacan 1000 is a simplified version of Alvacan 4000, which can be used where surgery and other cancer therapy are not sufficient. Where Alvacan 4000 should preferably have tumor tissue from the patient, only a blood sample is used for Alvacan 1000. This makes the process both cheaper and faster.
Do not hesitate to contact us with questions regarding Alvacan 1000 & 4000.